“The impact on medical science is, in my view, at the foothills of enormous developments and that change is perhaps not truly recognised yet.”
Mark Battersby is a freelance journalist
Article continues after advert
Page 3 of 3
Derisking your portfolio in a post-Covid landscape
This article is part of
Guide to Multi-Asset
Supported by
‘Supported by’ describes commercial support of our
independent journalism. It indicates funding for an
editorial project or content that is commissioned by
Financial Times editors and produced by FT journalists.
